Oyster farming by women self help groups At Wadatar, Sindhudurg district in Maharashtra State

Practical dissemination of bivalve farming technologies in the potential maritime locations of Sindhudurg district was undertaken by ICAR-CMFRI. Initially a demoyster farm was setup in Wadatar, in Sindhudurg District under the UNDP-GEF funded project “Demonstration of bivalve farming at Sindhudurg District in the State of Maharashtra”. The training and demonstration for oyster farming was given to the Self Help Groups-SHG, “Prasidhi” consisting of 10 members. Five hundred strings containing 7,000 numbers of oysters were harvested. Each string consists of 10-15 live oysters. Live oysters were sold at the rate of Rs. 150-200 per dozen. A total profi t of Rs.45,000 was realized. This successful case study can be used as a case manual for group action for bivalve farming technology

Manual on Edible Oyster and Green Mussel Farming कालवं आणि काकई संवर्धन तंत्र प्रशिक्षण पुस्तिका

Manual on Edible Oyster and Green Mussel Farming कालवं आणि काकई संवर्धन तंत्र प्रशिक्षण पुस्तिका (Marathi Version

Overview Of Fixture Design For Indian Industries

Industries are looking forward for the revolution-4.0 in coming years. It is expected that, most of the processes will be designed with automation applications. Despite of this, mechanical industries are using the basic structure in processing the small mechanical parts of the product called fixture. Fixtures are contributing to make the final finishing effective and many times in other processes like drilling also. Small industries in India are looking forward for the affordable and effective changes in the process of manufacturing. Many operations like turning, shaping, drilling requires skills for the workers and any mistake done by the workers may results in severe accidents. Fixture helps in these operations by providing the support to the working piece. The metal piece needs to be stable, when mechanical operations are performed over it. This is advantageous over the safety of worker and improving the accuracy of final product

Not Available

Not AvailablePractical dissemination of bivalve farming technologies in the potential maritime locations of Sindhudurg district was undertaken by ICAR-CMFRI. Initially a demoyster farm was setup in Wadatar, in Sindhudurg District under the UNDP-GEF funded project “Demonstration of bivalve farming at Sindhudurg District in the State of Maharashtra”. The training and demonstration for oyster farming was given to the Self Help Groups-SHG, “Prasidhi” consisting of 10 members. Five hundred strings containing 7,000 numbers of oysters were harvested. Each string consists of 10-15 live oysters. Live oysters were sold at the rate of Rs. 150-200 per dozen. A total profi t of Rs.45,000 was realized. This successful case study can be used as a case manual for group action for bivalve farming technology.Not Availabl

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

BackgroundTreatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of individual drugs, and the optimal number and duration of treatment with those drugs in patients with multidrug-resistant tuberculosis.MethodsIn this individual patient data meta-analysis, we searched MEDLINE, Embase, and the Cochrane Library to identify potentially eligible observational and experimental studies published between Jan 1, 2009, and April 30, 2016. We also searched reference lists from all systematic reviews of treatment of multidrug-resistant tuberculosis published since 2009. To be eligible, studies had to report original results, with end of treatment outcomes (treatment completion [success], failure, or relapse) in cohorts of at least 25 adults (aged >18 years). We used anonymised individual patient data from eligible studies, provided by study investigators, regarding clinical characteristics, treatment, and outcomes. Using propensity score-matched generalised mixed effects logistic, or linear regression, we calculated adjusted odds ratios and adjusted risk differences for success or death during treatment, for specific drugs currently used to treat multidrug-resistant tuberculosis, as well as the number of drugs used and treatment duration.FindingsOf 12 030 patients from 25 countries in 50 studies, 7346 (61%) had treatment success, 1017 (8%) had failure or relapse, and 1729 (14%) died. Compared with failure or relapse, treatment success was positively associated with the use of linezolid (adjusted risk difference 0·15, 95% CI 0·11 to 0·18), levofloxacin (0·15, 0·13 to 0·18), carbapenems (0·14, 0·06 to 0·21), moxifloxacin (0·11, 0·08 to 0·14), bedaquiline (0·10, 0·05 to 0·14), and clofazimine (0·06, 0·01 to 0·10). There was a significant association between reduced mortality and use of linezolid (-0·20, -0·23 to -0·16), levofloxacin (-0·06, -0·09 to -0·04), moxifloxacin (-0·07, -0·10 to -0·04), or bedaquiline (-0·14, -0·19 to -0·10). Compared with regimens without any injectable drug, amikacin provided modest benefits, but kanamycin and capreomycin were associated with worse outcomes. The remaining drugs were associated with slight or no improvements in outcomes. Treatment outcomes were significantly worse for most drugs if they were used despite in-vitro resistance. The optimal number of effective drugs seemed to be five in the initial phase, and four in the continuation phase. In these adjusted analyses, heterogeneity, based on a simulated I2 method, was high for approximately half the estimates for specific drugs, although relatively low for number of drugs and durations analyses.InterpretationAlthough inferences are limited by the observational nature of these data, treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis. These findings emphasise the need for trials to ascertain the optimal combination and duration of these drugs for treatment of this condition.FundingAmerican Thoracic Society, Canadian Institutes of Health Research, US Centers for Disease Control and Prevention, European Respiratory Society, Infectious Diseases Society of America

Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic

Childhood cancer is a leading cause of death. It is unclear whether the COVID-19 pandemic has impacted childhood cancer mortality. In this study, we aimed to establish all-cause mortality rates for childhood cancers during the COVID-19 pandemic and determine the factors associated with mortality